Related Experiment Video
Updated: Mar 9, 2026

06:09
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
Published on: February 9, 2020
13.7K
Neck lymph node metastases from unknown primary.
Alberto Daniele Arosio1, Lorenzo Pignataro2, Renato Maria Gaini1
1Department of Otorhinolaryngology, School of Medicine and Surgery, University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy.
Cancer Treatment Reviews
|December 28, 2016
Summary
Metastatic cervical carcinoma of unknown primary is rare. This review outlines diagnostic work-up and treatment strategies, favoring surgery for early-stage disease and combined therapy for advanced cases.
Area of Science:
- Oncology
- Head and Neck Surgery
Background:
- Metastatic cervical carcinoma from an unknown primary site presents a diagnostic and therapeutic challenge.
- Limited evidence exists for optimal management strategies.
Purpose of the Study:
- To review the literature and establish clinical indications for the diagnosis and treatment of metastatic cervical carcinoma of unknown primary.
- To provide evidence-based guidance for clinicians managing this rare condition.
Main Methods:
- Systematic review of available literature.
- Analysis of diagnostic modalities including imaging (CT, MRI, PET), fibroscopy, fine needle aspiration, and panendoscopy.
- Evaluation of treatment approaches based on disease stage and histopathological findings.
Main Results:
- A thorough diagnostic work-up is essential, incorporating multiple imaging and invasive procedures.
- Early-stage disease (N1, N2a, no extracapsular extension) may be treated with single modality therapy, with a preference for surgery for precise staging.
- Advanced disease necessitates combined treatment, such as resection with adjuvant radiation (±chemotherapy) or primary chemoradiation (±post-therapy neck dissection).
Conclusions:
- Comprehensive diagnostic evaluation is crucial for accurate staging.
- Treatment should be tailored to disease extent, with surgery preferred for early-stage metastatic cervical carcinoma of unknown primary.
- Combined modality treatment is indicated for more advanced presentations.

